BEGIN:VCALENDAR VERSION:2.0 PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90// CALSCALE:GREGORIAN UID:63303062-6332-4062-a232-323234306530 BEGIN:VEVENT UID:65f748a84406490374da33d12fecc3c5db1873c4@swoogo.com DTSTAMP:20260517T143630Z DESCRIPTION:This collaboration project between the University Medical Cente r Hamburg-Eppendorf and Eppendorf aims to improve treatment strategies for colorectal carcinoma by using automated liquid handling and 3D cell cultu res. Colorectal carcinoma is one of the most common cancers\, but the succ ess of therapy is limited due to drug resistance. This necessitates the ex ploration of novel and more effective therapeutic approaches. An automated workflow has the potential to revolutionize drug testing by providing inc reased accuracy\, speed\, and standardization\, ultimately resulting in hi gh-quality data.\n\nIn this talk\, we introduce the configuration and meth ods for automated tumor spheroid generation using the epMotion 5073t platf orm. The spheroids then were used for preclinical drug testing\, and the v iability and metabolism after treatment was assessed utilizing an automate d cell-based assay. Automated cell seeding and compound testing with epMot ion significantly reduces the workload required for routine procedures and consistently generates reproducible results. DTSTART:20240410T130000Z DTEND:20240410T133000Z LAST-MODIFIED:20260517T143630Z LOCATION:https://event.eppendorf.com/labchannel/v/s-2021299 SEQUENCE:0 STATUS:CONFIRMED SUMMARY:Automated Tumor Spheroid Formation and Preclinical Drug Testing on epMotion® 5073t TRANSP:OPAQUE X-ALT-DESC;FMTTYPE=text/html:

This collaboration project between the Univ ersity Medical Center Hamburg-Eppendorf and Eppendorf aims to improve trea tment strategies for colorectal carcinoma by using automated liquid handli ng and 3D cell cultures. Colorectal carcinoma is one of the most common ca ncers\, but the success of therapy is limited due to drug resistance. This necessitates the exploration of novel and more effective therapeutic appr oaches. An automated workflow has the potential to revolutionize drug test ing by providing increased accuracy\, speed\, and standardization\, ultima tely resulting in high-quality data.

\n\n

In this talk\, we introduce the configuration and methods for automated tumor spheroid generation usi ng the epMotion 5073t platform. The spheroids then were used for preclinic al drug testing\, and the viability and metabolism after treatment was ass essed utilizing an automated cell-based assay. Automated cell seeding and compound testing with epMotion significantly reduces the workload required for routine procedures and consistently generates reproducible results. BEGIN:VALARM UID:34636161-3632-4466-b666-626434326335 ACTION:DISPLAY DESCRIPTION:This collaboration project between the University Medical Cente r Hamburg-Eppendorf and Eppendorf aims to improve treatment strategies for colorectal carcinoma by using automated liquid handling and 3D cell cultu res. Colorectal carcinoma is one of the most common cancers\, but the succ ess of therapy is limited due to drug resistance. This necessitates the ex ploration of novel and more effective therapeutic approaches. An automated workflow has the potential to revolutionize drug testing by providing inc reased accuracy\, speed\, and standardization\, ultimately resulting in hi gh-quality data.\n\nIn this talk\, we introduce the configuration and meth ods for automated tumor spheroid generation using the epMotion 5073t platf orm. The spheroids then were used for preclinical drug testing\, and the v iability and metabolism after treatment was assessed utilizing an automate d cell-based assay. Automated cell seeding and compound testing with epMot ion significantly reduces the workload required for routine procedures and consistently generates reproducible results. TRIGGER:-PT15M END:VALARM END:VEVENT END:VCALENDAR